Quick Takeaways
- BlackRock, Inc. filed SCHEDULE 13G/A for TG THERAPEUTICS, INC. Common Stock (TGTX).
- Disclosed ownership: 13%.
- Date of event: 31 Mar 2025.
BlackRock, Inc. - 31 Mar 2025 SCHEDULE 13G/A Report for TG THERAPEUTICS, INC. Common Stock (TGTX)
- Filing Manager
- BlackRock, Inc.
- Reporting Manager
- BlackRock, Inc.
- Security
- TG THERAPEUTICS, INC. Common Stock
- Symbol
- TGTX
- Shares outstanding
- 157,303,766 shares
- Disclosed Ownership
- 20,134,882 shares
- Ownership
- 13%
- Form type
- SCHEDULE 13G/A
- Filing time
- 30 Apr 2025, 12:45:21 UTC
- Date of event
- 31 Mar 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"BlackRock, Inc. disclosed 13% ownership in TG THERAPEUTICS, INC. Common Stock (TGTX) on 31 Mar 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 30 Apr 2025, 12:45.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 13% | 20,134,882 | 19,967,724 | 0 | Spencer Fleming | Managing Director |